Cellosaurus logo
expasy logo

Cellosaurus CHLA-134 (CVCL_6589)

[Text version]
Cell line name CHLA-134
Accession CVCL_6589
Resource Identification Initiative To cite this cell line use: CHLA-134 (RRID:CVCL_6589)
Sequence variations
Disease Neuroblastoma (NCIt: C3270)
Neuroblastoma (ORDO: Orphanet_635)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Sex unspecified
Age at sampling Children
Category Cancer cell line
STR profile Source(s): COG

Markers:
AmelogeninX
CSF1PO11,13
D2S133817,24
D3S135815
D5S81811,13
D7S82012,13
D8S117913,14
D13S31711
D16S5399,12
D18S5113,14
D19S43312.2,14
D21S1131.2,33.2
FGA20,23
TH017
TPOX8
vWA14,16

Run an STR similarity search on this cell line
Publications

PubMed=9850071
Nino Keshelava, Robert C. Seeger, Susan Groshen, Charles Patrick Reynolds;
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
Cancer Res. 58:5396-5405(1998)

PubMed=11507071
Nino Keshelava, Juan J. Zuo, Ping Chen, Sitara N. Waidyaratne, Marian C. Luna, Charles Joseph Gomer, Timothy J. Triche, Charles Patrick Reynolds;
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
Cancer Res. 61:6185-6193(2001)

Cross-references
Encyclopedic resources Wikidata; Q54812159
Polymorphism and mutation databases IARC_TP53; 23828
Entry history
Entry creation04-Apr-2012
Last entry update19-Dec-2024
Version number15